In this conversation, we talk with Sri Kosuri, CEO & co-founder of Octant. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases. We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more!
Mentioned in this conversation
Chapters
00:00 Welcome and introducing Octant
01:56 New tools for engineering biology
07:48 Genetics and complex disease
16:13 Measuring many biological responses at once
21:03 From a platform to drug programs
29:04 What the next stage of biology could enable
35:58 Finding Octant and closing
Links
Thanks for listening to this episode of the Build the Future Podcast. This is a project by World's Fair Co. You can learn more at worldsfair.org.
